- ISIN
- US05380C1027
- CUSIP
- 05380C102
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Oct 1, 2019
Highlights
- Market Cap
- $109.31M
- Enterprise Value
- $102.98M
- EPS (TTM)
- -$0.37
- Total Revenue (TTM)
- $72.35M
- Gross Profit (TTM)
- $58.86M
- EBITDA (TTM)
- -$12.27M
- Year Range
- $3.22 - $7.12
- Target Price
- $6.75
- ROA (TTM)
- -87.96%
- ROE (TTM)
- 195.71%
- Avg. Volume (1M)
- 268K
- Avg. Volume Value (1M)
- $1.28M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
RCEL Performance Chart
AVITA Medical, Inc. (RCEL) is up 27.5% since the beginning of the year. At $4 per share, RCEL is trading 38.2% below its 52-week high of $7. Investors who bought $1,000 worth of RCEL shares 5 years ago would now be looking at an investment worth $237.
Loading charts...
Compare this symbol against anything
Returns By Period
AVITA Medical, Inc. (RCEL) has returned 27.54% so far this year and -14.73% over the past 12 months.
AVITA Medical, Inc.
- 1D
- -2.00%
- 1M
- -13.04%
- 6M
- -0.23%
- YTD
- 27.54%
- 1Y
- -14.73%
- 3Y*
- -39.41%
- 5Y*
- -24.99%
- 10Y*
- —
- ALL TIME*
- -28.05%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
RCEL Monthly Returns History
Based on dividend-adjusted daily data since Oct 1, 2019, RCEL's average daily return is -0.02%, while the average monthly return is -0.84%.
Historically, 41% of months were positive and 59% were negative. The best month was Jun 2023 with a return of +49.0%, while the worst month was Apr 2024 at -47.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 10 months.
On a daily basis, RCEL closed higher 47% of trading days. The best single day was Sep 15, 2025 with a return of +48.3%, while the worst single day was Jan 8, 2025 at -36.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 27.83% | 14.06% | -26.44% | 16.76% | 0.23% | -4.62% | 6.54% | 27.54% | |||||
| 2025 | -28.91% | -0.00% | -10.55% | 19.04% | -42.00% | -5.87% | 0.19% | -18.11% | 17.74% | -24.27% | -4.39% | -6.76% | -73.05% |
| 2024 | 22.16% | 8.17% | -11.58% | -47.60% | 14.40% | -17.59% | 23.74% | -4.49% | 14.53% | -5.78% | 26.93% | -0.16% | -6.71% |
| 2023 | 41.52% | 43.58% | 4.18% | 11.10% | -26.42% | 48.95% | 19.05% | -19.51% | -10.37% | -36.28% | 14.50% | 28.71% | 107.88% |
| 2022 | -19.28% | -4.86% | -7.83% | -28.07% | -6.56% | -16.67% | 18.53% | 9.77% | -14.72% | -7.21% | 35.99% | -0.75% | -44.91% |
| 2021 | 32.88% | -11.95% | -8.83% | 4.14% | -12.50% | 13.62% | -9.70% | 9.07% | -12.32% | -7.05% | -16.45% | -12.94% | -35.52% |
Benchmark Metrics
AVITA Medical, Inc. has an annualized alpha of -24.73%, beta of 1.48, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since October 01, 2019.
- This stock participated in 178.58% of S&P 500 Index downside but only 20.66% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -24.73%
- Beta
- 1.48
- R²
- 0.16
- Upside Capture
- 20.66%
- Downside Capture
- 178.58%
Return for Risk
Risk / Return Rank
RCEL ranks 38 for risk / return — above 38% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for AVITA Medical, Inc. (RCEL) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RCEL | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -1.60 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.25 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.33 | 2.00 | -2.33 |
| Martin ratioReturn relative to average drawdown | -0.47 | 8.49 | -8.97 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the AVITA Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AVITA Medical, Inc. was 94.08%, occurring on Dec 17, 2025. The portfolio has not yet recovered.
The current AVITA Medical, Inc. drawdown is 92.03%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-94.08%Dec 2025 | 5y 10mo | — | 6y 5moFeb 2020 - now | — |
-26.80%Nov 2019 | 8d | 1mo 24d | 2mo 2dNov 2019 - Jan 2020 | — |
-17.63%Jan 2020 | 14d | 11d | 25dJan 2020 - Feb 2020 | — |
-15.26%Oct 2019 | 6d | 8d | 14dOct 2019 - Nov 2019 | — |
-14.63%Oct 2019 | 1d | 15d | 16dOct 2019 - Oct 2019 | — |
Drawdown Indicators
| RCEL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.08% | -56.78% | -37.30% |
Max Drawdown (1Y)Largest decline over 1 year | -51.63% | -9.10% | -42.53% |
Max Drawdown (3Y)Largest decline over 3 years | -82.48% | -18.90% | -63.58% |
Max Drawdown (5Y)Largest decline over 5 years | -84.35% | -25.43% | -58.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -92.03% | -1.58% | -90.45% |
Average DrawdownAverage peak-to-trough decline | -72.72% | -10.70% | -62.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.90% | 2.14% | +33.76% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of AVITA Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how AVITA Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RCEL relative to other companies in the Medical Devices industry. Currently, RCEL has a P/S ratio of 7.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with RCEL
Add AVITA Medical, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with RCEL